Genital Herpes Vaccine

About Rational Vaccines

Rational Vaccines is a private, pre-revenue biotech firm founded in 2015, headquartered in Boston, USA, targeting the vast unmet medical need in herpes simplex virus infections. The company's core approach involves a proprietary platform for live-attenuated vaccine design, with its lead program focused on genital herpes. While primarily targeting HSV, the company has also indicated exploration of its technology for COVID-19, though its primary focus and stated goal is the eradication of herpes.

Therapeutic Areas